Suraksha Diagnostic IPO Day 3 Updates: Key Highlights, Subscription Status, and Insights

Suraksha Diagnostic IPO Day 2 Subscription Status 

(December 2, 2024, End of Day)

On the second day of the Suraksha Diagnostic IPO, the overall subscription level reached 0.25 times the shares available. Retail Individual Investors (RII) subscribed to 0.45 times their allocated portion, while Non-Institutional Investors (NII), including high-net-worth individuals, subscribed to 0.13 times their quota. Meanwhile, the Qualified Institutional Buyers (QIBs) segment showed no participation, with a subscription rate of 0.00 times.

Suraksha Diagnostic IPO Day 1 Subscription Status

(November 29, 2024, End of Day)

On Day 1 of the Suraksha Diagnostic IPO, which opened on November 29, 2024, the overall subscription stood at 0.11 times. Among investor categories, the Retail Individual Investors (RII) showed the most interest, with a subscription level of 0.20 times. Non-Institutional Investors (NII) or high-net-worth individuals subscribed 0.04 times, while Qualified Institutional Buyers (QIBs) registered no subscriptions yet, with a 0.00 times response. These early figures indicate a slow start to the IPO across all investor categories.

Suraksha Diagnostic IPO Details

The Suraksha Diagnostic IPO opened for subscription on November 29, 2024, and will close today, December 3, 2024. The issue size is ₹846.25 crore, with a price band of ₹420-441 per share. Allotment is expected on December 4, 2024, and the listing will take place on December 6, 2024, on both BSE and NSE.

Utilization of IPO Proceeds

As the IPO consisted solely of an OFS, the primary objective was to provide an exit opportunity for existing shareholders. The company does not raise any capital through this offering.

This overview provides a comprehensive understanding of the key aspects of the Suraksha Diagnostic IPO. However, potential investors should conduct thorough research and consult with financial advisors before making any investment decisions.

Suraksha Diagnostic Overview:

Suraksha Diagnostic provides a comprehensive range of healthcare services, including pathology and radiology tests and medical consultations. Its operations are anchored by a central reference laboratory, complemented by 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centers and 166 sample collection locations (as of June 30, 2024). The company maintains a strong foothold in four states across Eastern and North-Eastern India: West Bengal, Bihar, Assam, and Meghalaya.

Financial Highlights (FY24):

Revenue from operations: ₹218.7 crore, reflecting a 15% increase compared to FY23.

Net profit: ₹23.1 crore, a nearly four-fold jump from ₹6 crore in FY23.

Key performance indicators